<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Guaifenesin, dextromethorphan, and phenylephrine: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Guaifenesin, dextromethorphan, and phenylephrine: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Guaifenesin, dextromethorphan, and phenylephrine: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="11537" href="/d/html/11537.html" rel="external">see "Guaifenesin, dextromethorphan, and phenylephrine: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F1698817"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Aquanaz [OTC];</li>
<li>Deconex DMX [OTC];</li>
<li>FT Tussin CF Adult [OTC];</li>
<li>Gcon DMX [OTC];</li>
<li>GoodSense Mucus Relief Child [OTC];</li>
<li>GoodSense Mucus/Congest/Cough [OTC];</li>
<li>Mucinex Childrens Freefrom [OTC];</li>
<li>Mucinex Cold Childrens [OTC];</li>
<li>Mucinex Congest &amp; Cough Child [OTC] [DSC];</li>
<li>Mucinex Cough &amp; Congest Child [OTC];</li>
<li>Mucinex Fast-Max Congest Cough [OTC];</li>
<li>Mucinex Freefrom Sev Cngst/Cgh [OTC] [DSC];</li>
<li>Mucinex Junior Cough/Congest [OTC];</li>
<li>NeoTuss-D [OTC] [DSC];</li>
<li>Nivanex DMX [OTC];</li>
<li>Robafen CF Multi-Symptom Cold [OTC];</li>
<li>Robitussin Child Cough/Cold CF [OTC];</li>
<li>Robitussin Peak Cold Multi-Sym [OTC];</li>
<li>Vanacof DMX [OTC] [DSC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F1699136"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Antitussive;</li>
<li>
                        Decongestant</li></ul></div>
<div class="block doa drugH1Div" id="F1699161"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:0em;display:inline">Also refer to specific product labeling.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="2fa976fa-dcd4-4f75-9d04-f818a4a62212">Cough/decongestant</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cough/decongestant:</b>
<b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Liquid:</p>
<p style="text-indent:-2em;margin-left:6em;">Mucinex Fast-Max Congest Cough: Guaifenesin 400 mg, dextromethorphan 20 mg, and phenylephrine 10 mg per 20 mL: 20 mL every 4 hours (maximum: 120 mL per 24 hours).</p>
<p style="text-indent:-2em;margin-left:6em;">Robitussin Peak Cold Multi-Symptom Cold: Guaifenesin 200 mg, dextromethorphan 20 mg, and phenylephrine 10 mg per 10 mL: 10 mL every 4 hours (maximum: 60 mL per 24 hours).</p>
<p style="text-indent:-2em;margin-left:4em;">Tablet:</p>
<p style="text-indent:-2em;margin-left:6em;">Deconex DMX: Guaifenesin 400 mg, dextromethorphan 17.5 mg, and phenylephrine 10 mg per tablet: One tablet every 4 hours (maximum: 6 tablets per 24 hours).</p>
<p style="text-indent:-2em;margin-left:6em;">Mucinex Fast-Max Congest Cough: Guaifenesin 200 mg, dextromethorphan 10 mg, and phenylephrine 5 mg per tablet: Two tablets every 4 hours (maximum: 12 tablets per 24 hours).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990547"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987882"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F1699162"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F1699160"><span class="drugH1">Dosing: Pediatric</span>
<p style="text-indent:0em;display:inline">Also refer to specific product labeling.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="2fa976fa-dcd4-4f75-9d04-f818a4a62212">Cough/decongestant</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cough/decongestant:</b> Oral:</p>
<p style="text-indent:-2em;margin-left:4em;">Tablet:</p>
<p style="text-indent:-2em;margin-left:6em;">Children 6 to 11 years (Deconex DMX): Guaifenesin 192.5 mg, dextromethorphan 8.75 mg, and phenylephrine 5 mg (1/2 tablet) every 4 hours; maximum: 3 tablets/24 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥12 years and Adolescents: Refer to adult dosing.</p>
<p style="text-indent:-2em;margin-left:4em;">Liquid (OTC labeling):</p>
<p style="text-indent:-2em;margin-left:6em;">Children 4 to 5 years (Mucinex Children's Congestion &amp; Cough): Oral: Guaifenesin 100 mg, dextromethorphan 5 mg, and phenylephrine 2.5 mg (5 mL) every 4 hours, not to exceed 30 mL/24 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Children 6 to 11 years (Mucinex Children's Congestion &amp; Cough): Oral: Guaifenesin 200 mg, dextromethorphan 10 mg, and phenylephrine 5 mg (10 mL) every 4 hours, not to exceed 60 mL/24 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥12 years and Adolescents (Robitussin Peak Cold Multi-Symptom Cold): Refer to adult dosing.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51159553"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51159554"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F1699146"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined. The following adverse events have been reported with the combination product. Also see individual agents.</p>
<p style="text-indent:-2em;margin-left:2em;">Cardiovascular: Circulatory shock, palpitations, tachycardia</p>
<p style="text-indent:-2em;margin-left:2em;">Central nervous system: Anxiety, central nervous system depression, convulsions, dizziness, drowsiness, excitability, fear, hallucination, headache, insomnia, irritability, nervousness</p>
<p style="text-indent:-2em;margin-left:2em;">Gastrointestinal: Nausea, vomiting</p>
<p style="text-indent:-2em;margin-left:2em;">Neuromuscular &amp; skeletal: Tremor, weakness</p>
<p style="text-indent:-2em;margin-left:2em;">Respiratory: Dyspnea</p></div>
<div class="block coi drugH1Div" id="F1699142"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">OTC labeling: When used for self-medication, do not exceed recommended dose, do not use with or within 14 days of stopping a monoamine oxidase inhibitor (MAOI), and do not use in children &lt;12 years of age (product specific; refer to manufacturer's labeling).</p>
<p style="text-indent:-2em;margin-left:2em;">Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block war drugH1Div" id="F1699143"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Debilitated patients: Use with caution in debilitated, sedated and/or patients confined to the supine position.</p>
<p style="text-indent:-2em;margin-left:4em;">• CYP2D6 poor metabolizers: Dextromethorphan is metabolized by hepatic CYP2D6. Poor metabolizers of CYP2D6 may have exaggerated or prolonged effects of dextromethorphan. Increased risk may be seen with concomitant use of potent CYP2D6 inhibitors; use with caution (Abduljalil 2010; Jurica 2012; Sager 2014; Zhou 2009).</p>
<p style="text-indent:-2em;margin-left:4em;">• Older adult: Use with caution in the elderly; may be more sensitive to adverse effects.</p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric: Use with caution in atopic children.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Cough: Appropriate use: Underlying cause of cough should be determined prior to prescribing. Re-evaluate if cough persists &gt;7 days.</p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): When used for self-medication (OTC), consult health care provider prior to use if you have persistent or chronic cough (associated with asthma, chronic obstructive pulmonary disease, emphysema, or smoking), cough is accompanied by excessive phlegm (mucous), heart disease, high BP, thyroid disease, diabetes, and/or trouble urinating due to an enlarged prostate gland. Discontinue use and contact health care provider if new symptoms occur, do not improve within 7 days, or are accompanied by fever, rash, or persistent headache, or if nervousness, dizziness, or sleeplessness occur.</p></div>
<div class="block foc drugH1Div" id="F1699168"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Liquid, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">FT Tussin CF Adult: Guaifenesin 100 mg, dextromethorphan hydrobromide 10 mg, and phenylephrine hydrochloride 5 mg per 5 mL (237 mL) [contains fd&amp;c red #40 (allura red ac dye), menthol, propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">GoodSense Mucus Relief Child: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL) [gluten free; contains edetate (edta) disodium, fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate, sorbitol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">GoodSense Mucus/Congest/Cough: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (177 mL) [contains disodium edta, fd&amp;c blue #1 (brilliant blue), fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate, sorbitol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Childrens Freefrom: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL) [alcohol free, caffeine free, dye free, no artificial color(s), no artificial flavor(s), sugar free; contains disodium edta, glycerin (soy), propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Cold Childrens: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL [DSC]) [contains edetate (edta) disodium, fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Cold Childrens: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL, 201 mL) [contains edetate (edta) disodium, fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate; berry flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Congest &amp; Cough Child: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (201 mL [DSC]) [contains edetate (edta) disodium, fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Cough &amp; Congest Child: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (201 mL) [contains fd&amp;c red #40 (allura red ac dye), glycerin (soy), propylene glycol, sodium benzoate, sorbitol; berry flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Fast-Max Congest Cough: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (180 mL [DSC]) [contains edetate (edta) disodium, fd&amp;c blue #1 (brilliant blue), propylene glycol, quinoline yellow (d&amp;c yellow #10), sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Fast-Max Congest Cough: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (180 mL) [contains edetate (edta) disodium, fd&amp;c blue #1 (brilliant blue), propylene glycol, quinoline yellow (d&amp;c yellow #10), sodium benzoate; menthol flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Fast-Max Congest Cough: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (266 mL) [contains edetate (edta) disodium, fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Fast-Max Congest Cough: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (180 mL) [contains edetate (edta) disodium, fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate; fruit flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Freefrom Sev Cngst/Cgh: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (180 mL [DSC]) [alcohol free, no artificial color(s), no artificial flavor(s), sugar free; contains edetate (edta) disodium, glycerin (soy), propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">NeoTuss-D: Guaifenesin 200 mg, dextromethorphan hydrobromide 30 mg, and phenylephrine hydrochloride 7.5 mg per 5 mL (474 mL [DSC]) [alcohol free, codeine free, dye free, sugar free; contains methylparaben, propylene glycol, propylparaben; raspberry flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Robafen CF Multi-Symptom Cold: Guaifenesin 100 mg, dextromethorphan hydrobromide 10 mg, and phenylephrine hydrochloride 5 mg per 5 mL (118 mL) [alcohol free; contains fd&amp;c red #40 (allura red ac dye), menthol, propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Robitussin Child Cough/Cold CF: Guaifenesin 50 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg per 5 mL (118 mL) [contains fd&amp;c red #40 (allura red ac dye), propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Robitussin Peak Cold Multi-Sym: Guaifenesin 100 mg, dextromethorphan hydrobromide 10 mg, and phenylephrine hydrochloride 5 mg per 5 mL (118 mL [DSC], 237 mL) [contains fd&amp;c red #40 (allura red ac dye), menthol, propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Vanacof DMX: Guaifenesin 396 mg, dextromethorphan hydrobromide 18 mg, and phenylephrine hydrochloride 10 mg per 15 mL (237 mL [DSC]) [alcohol free, dye free, gluten free, sugar free; contains menthol, propylene glycol, sodium benzoate]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Guaifenesin 200 mg, dextromethorphan hydrobromide 18 mg, and phenylephrine hydrochloride 10 mg per 15 mL (240 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Aquanaz: Guaifenesin 400 mg, dextromethorphan hydrobromide 15 mg, and phenylephrine hydrochloride 10 mg [contains fd&amp;c blue #2 (indigotine,indigo carmine)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Deconex DMX: Guaifenesin 385 mg, dextromethorphan hydrobromide 17.5 mg, and phenylephrine hydrochloride 10 mg [DSC] [contains fd&amp;c yellow #6 (sunset yellow), quinoline yellow (d&amp;c yellow #10)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Deconex DMX: Dextromethorphan hydrobromide 17.5 mg, guaifenesin 400 mg, and phenylephrine hydrochloride 10 mg [scored; contains fd&amp;c yellow #6 (sunset yellow), quinoline yellow (d&amp;c yellow #10)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gcon DMX: Guaifenesin 385 mg, dextromethorphan hydrobromide 17.5 mg, and phenylephrine hydrochloride 10 mg [scored; contains fd&amp;c yellow #6 (sunset yellow), quinoline yellow (d&amp;c yellow #10)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Fast-Max Congest Cough: Guaifenesin 200 mg, dextromethorphan hydrobromide 10 mg, and phenylephrine hydrochloride 5 mg [contains fd&amp;c blue #2 (indigo carm) aluminum lake, fd&amp;c red #40(allura red ac)aluminum lake]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mucinex Junior Cough/Congest: Guaifenesin 100 mg, dextromethorphan hydrobromide 5 mg, and phenylephrine hydrochloride 2.5 mg [contains corn starch, fd&amp;c blue #2 (indigo carm) aluminum lake, fd&amp;c red #40(allura red ac)aluminum lake]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nivanex DMX: Guaifenesin 380 mg, dextromethorphan hydrobromide 15 mg, and phenylephrine hydrochloride 10 mg [scored; contains fd&amp;c yellow #6 (sunset yellow), quinoline yellow (d&amp;c yellow #10)]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Guaifenesin 385 mg, dextromethorphan hydrobromide 17.5 mg, and phenylephrine hydrochloride 10 mg [DSC]</p></div>
<div class="block geq drugH1Div" id="F1698818"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16322881"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Actinel DM Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-20-400 mg/5 mL (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Desgen DM Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5-10-100 mg/5 mL (per mL): $0.03</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Desgen Pediatric Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-50 mg/mL (per mL): $0.24</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (G-Tron Ped Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-15-350 mg/5 mL (per mL): $0.05</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (G-Tron Pediatric Drops Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-100 mg/mL (per mL): $0.20</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (G-Tusicof Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-20-400 mg/5 mL (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Giltuss Cough &amp; Cold Childrens Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">7.5-150-5 mg/2.5 mL (per mL): $0.06</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Giltuss Cough &amp; Cold Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-15-300 mg/5 mL (per mL): $0.06</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Mucinex Childrens Freefrom Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-100 mg/5 mL (per mL): $0.09</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Mucinex Cold Childrens Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-100 mg/5 mL (per mL): $0.09</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Mucinex Cough &amp; Congest Child Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-100 mg/5 mL (per mL): $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Mucinex Fast-Max Congest Cough Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-100 mg/5 mL (per mL): $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Phenylephrine-DM-GG Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-18-200 mg/15 mL (per mL): $0.11</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Robitussin Child Cough/Cold CF Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-50 mg/5 mL (per mL): $0.05</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Robitussin Peak Cold Multi-Sym Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5-10-100 mg/5 mL (per mL): $0.03</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tusicof Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-20-400 mg/5 mL (per mL): $0.11</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tusnel DM Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-20-400 mg/5 mL (per mL): $0.03</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tusnel DM Pediatric Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-75 mg/5 mL (per mL): $0.03</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tusnel-DM Pediatric Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.25-2.5-25 mg/mL (per mL): $0.30</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tussi-Pres Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5-10-200 mg/5 mL (per mL): $0.15</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tussi-Pres Pediatric Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-75 mg/5 mL (per mL): $0.06</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tusslin Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-28-388 mg/5 mL (per mL): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Tusslin Pediatric Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-7.5-88 mg/mL (per mL): $0.17</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Liquid</b> (Vanacof DM Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-18-200 mg/15 mL (per mL): $0.12</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Giltuss Cough &amp; Cold Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-28-388 mg (per each): $0.45</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Mucinex Fast-Max Congest Cough Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5-10-200 mg (per each): $0.65</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Mucinex Junior Cough/Congest Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2.5-5-100 mg (per each): $0.74</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Nivanex DMX Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-15-380 mg (per each): $0.60</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Tusicof Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">10-20-400 mg (per each): $0.45</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Vanatab DM Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5-9-198 mg (per each): $1.07</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F50148395"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Oral: </b>Only use dosing cup provided with liquid formulations.</p></div>
<div class="block admp drugH1Div" id="F52622704"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: Administer without regards to meals; if GI distress, take with food.</p>
<p style="text-indent:-2em;margin-left:2em;">Liquid, syrup: Only use dosing cup provided with liquid formulations or calibrated measuring device.</p></div>
<div class="block use drugH1Div" id="F1699137"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Cough/decongestant:</b> Temporary control of nasal congestion and cough due to minor throat and bronchial irritation associated with the common cold, hay fever, or other upper respiratory allergies; help loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive; reduces swelling of nasal passages</p></div>
<div class="block cyt drugH1Div" id="F1699150"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">Refer to individual components.</p></div>
<div class="block dri drugH1Div" id="F1699149"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Acetaminophen: May increase the serum concentration of Phenylephrine (Systemic).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ajmaline: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Alpha1-Blockers: May diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Artemether and Lumefantrine: May increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Atomoxetine: May enhance the hypertensive effect of Sympathomimetics. Atomoxetine may enhance the tachycardic effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Atropine (Systemic): May enhance the hypertensive effect of Alpha1-Agonists.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Benzylpenicilloyl Polylysine: Alpha1-Agonists may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Consider delaying skin testing until alpha1-agonists are no longer required, or use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Bromocriptine: May enhance the hypertensive effect of Alpha1-Agonists. Management: Consider alternatives to this combination when possible. If combined, monitor for hypertension and tachycardia, and do not coadminister these agents for more than 10 days.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cannabinoid-Containing Products: May enhance the tachycardic effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Chloroprocaine (Systemic): May enhance the hypotensive effect of Phenylephrine (Systemic).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">CloZAPine: May diminish the therapeutic effect of Phenylephrine (Systemic).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cocaine (Topical): May enhance the hypertensive effect of Sympathomimetics. Management: Consider alternatives to use of this combination when possible. Monitor closely for substantially increased blood pressure or heart rate and for any evidence of myocardial ischemia with concurrent use.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">CYP2D6 Inhibitors (Moderate): May increase the serum concentration of Dextromethorphan.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">CYP2D6 Inhibitors (Strong): May increase the serum concentration of Dextromethorphan.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Disulfiram: May enhance the adverse/toxic effect of Products Containing Ethanol. Management: Do not use disulfiram with dosage forms that contain ethanol.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Doxofylline: Sympathomimetics may enhance the adverse/toxic effect of Doxofylline. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ergot Derivatives (Vasoconstrictive CYP3A4 Substrates): May enhance the vasoconstricting effect of Alpha1-Agonists.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">FentaNYL: Decongestants may decrease the serum concentration of FentaNYL. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Guanethidine: May enhance the arrhythmogenic effect of Sympathomimetics. Guanethidine may enhance the hypertensive effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Hyaluronidase: May enhance the vasoconstricting effect of Phenylephrine (Systemic). Management: Do not use hyaluronidase to enhance the dispersion or absorption of phenylephrine. Use of hyaluronidase for other purposes in patients receiving phenylephrine may be considered as clinically indicated.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Iobenguane Radiopharmaceutical Products: Alpha1-Agonists may diminish the therapeutic effect of Iobenguane Radiopharmaceutical Products.  Management: Discontinue all drugs that may inhibit or interfere with catecholamine transport or uptake for at least 5 biological half-lives before iobenguane administration. Do not administer these drugs until at least 7 days after each iobenguane dose.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Kratom: May enhance the adverse/toxic effect of Sympathomimetics.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Levothyroxine: May enhance the adverse/toxic effect of Sympathomimetics. Specifically, the risk of coronary insufficiency may be increased in patients with coronary artery disease. Levothyroxine may enhance the therapeutic effect of Sympathomimetics. Sympathomimetics may enhance the therapeutic effect of Levothyroxine.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Lisuride: May enhance the hypertensive effect of Alpha1-Agonists.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Memantine: NMDA Receptor Antagonists may enhance the adverse/toxic effect of Memantine. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methotrimeprazine: Products Containing Ethanol may enhance the adverse/toxic effect of Methotrimeprazine. Specifically, a disulfiram-like reaction may occur and CNS depressant effects may be increased.  Management: Avoid products containing alcohol in patients treated with methotrimeprazine.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Monoamine Oxidase Inhibitors: Dextromethorphan may enhance the serotonergic effect of Monoamine Oxidase Inhibitors. This may cause serotonin syndrome. <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ornidazole: May enhance the adverse/toxic effect of Products Containing Ethanol. Specifically, a disulfiram-like reaction may occur.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Ozanimod: May enhance the hypertensive effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Parecoxib: May increase the serum concentration of Dextromethorphan.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates (High risk with Inhibitors). Peginterferon Alfa-2b may increase the serum concentration of CYP2D6 Substrates (High risk with Inhibitors).<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Pergolide: May enhance the hypertensive effect of Alpha1-Agonists.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Propacetamol: May increase the serum concentration of Phenylephrine (Systemic). Management: Monitor patients closely for increased side effects of phenylephrine if propacetamol is used concomitantly. Patients with underlying blood pressure issues or arrhythmias may need closer monitoring and may warrant consideration of alternative therapies.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Secnidazole: Products Containing Ethanol may enhance the adverse/toxic effect of Secnidazole. <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Selective Serotonin Reuptake Inhibitors (Strong CYP2D6 Inhibitors): Dextromethorphan may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors (Strong CYP2D6 Inhibitors). This could result in serotonin syndrome. Selective Serotonin Reuptake Inhibitors (Strong CYP2D6 Inhibitors) may increase the serum concentration of Dextromethorphan.  Management: Consider alternatives to this drug combination. The dose of dextromethorphan/bupropion product should not exceed 1 tablet once daily. Monitor for signs and symptoms of serotonin syndrome/serotonin toxicity.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Serotonergic Agents (High Risk): Dextromethorphan may enhance the serotonergic effect of Serotonergic Agents (High Risk). This could result in serotonin syndrome.  Management: Monitor for signs and symptoms of serotonin syndrome/serotonin toxicity (eg, hyperreflexia, clonus, hyperthermia, diaphoresis, tremor, autonomic instability, mental status changes) when these agents are combined.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Solriamfetol: Sympathomimetics may enhance the hypertensive effect of Solriamfetol. Sympathomimetics may enhance the tachycardic effect of Solriamfetol. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tedizolid: May enhance the hypertensive effect of Sympathomimetics. Tedizolid may enhance the tachycardic effect of Sympathomimetics.<i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F1699139"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Refer to individual monographs.</p></div>
<div class="block brc drugH1Div" id="F1699141"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Refer to individual monographs.</p></div>
<div class="block pha drugH1Div" id="F1699155"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">See individual agents.</p></div>
<div class="block phk drugH1Div" id="F1699157"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">See individual agents.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F52397382"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Nonar</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Tussex</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Dimacol | Flemigor</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Dibalsam congest | Neo silenai expectorante | Pharmalatum e | Pulmol compuesto | Zaytam compositum</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Actidom dmx | Actinel dm | Albatussin | Albatussin sr f | Altipres | Bio-Tussi | Bio-Tussi Pediatric | Biobron dx | Biobron SF | Biocotron D | Biodesp DM | Biogil | Biogtuss nf | Broncotron d | Brontuss DX | Brontuss sf | Brontuss sf-nr | Children's mucinex congestion &amp; cough | Children's mucinex multi symptom cold | Deconex DM | Desgen dm | Despec dm | Dextromethorphan Hbr Guaifenesin Phenylephrine Hcl | Dometuss dmx | Duravent dm | Endacon | Endacon DM | Exactuss | Exetuss DM | G supress dx | G Tusicof | G-tron ped | Genantuss | Genetuss | Gfn/Dm/Pe | Giltuss | Giltuss cough &amp; cold | Giltuss pediatric | Giltuss tr | Maxiphen DMX | Mucinex fast max severe congestion and cough | Numonyl dx | Pdm gg | Pres gen | Relhist dmx | Robitussin cough &amp; cold cf max | Tusicof | Tussafed-ex | Tussi pres | Tussi-pres pediatric | Tussilan G | Tusslin | Vanacof dm | Vanacof dmx | Vanatab dm</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Stona cough</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-20881950">
<a name="20881950"></a>Abduljalil K, Frank D, Gaedigk A, et al. Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan. <i>Clin Pharmacol Ther</i>. 2010;88(5):643-651. doi: 10.1038/clpt.2010.137.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/guaifenesin-dextromethorphan-and-phenylephrine-drug-information/abstract-text/20881950/pubmed" id="20881950" target="_blank">20881950</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Deconex DMX (dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride) [prescribing information]. Huntsville, AL: Poly Pharmaceuticals; June 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22548589">
<a name="22548589"></a>Jurica J, Bartecek R, Zourkova A, et al. Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice. <i>J Clin Pharm Ther</i>. 2012;37(4):486-490. doi:10.1111/j.1365-2710.2012.01333.x.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/guaifenesin-dextromethorphan-and-phenylephrine-drug-information/abstract-text/22548589/pubmed" id="22548589" target="_blank">22548589</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Mucinex Fast Max Caplets (guaifenesin, dextromethorphan, and phenylephrine) [prescribing information]. Parsippany, NJ: RB Health US LLC; received June 10, 2022.</div>
</li>
<li>
<div class="reference">
                  Mucinex Fast Max Liquid (guaifenesin, dextromethorphan, and phenylephrine) [prescribing information]. Parsippany, NJ: RB Health US LLC; received June 10, 2022.</div>
</li>
<li>
<div class="reference">
                  Robitussin Peak Cold Multi-Symptom Cold (dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride) [prescribing information]. Available at: https://www.robitussin.com/products/multi-symptom-cold-cf. Accessed June 10, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24569517">
<a name="24569517"></a>Sager JE, Lutz JD, Foti RS, et al. Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4. <i>Clin Pharmacol Ther</i>. 2014;95(6):653-662. doi: 10.1038/clpt.2014.50.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/guaifenesin-dextromethorphan-and-phenylephrine-drug-information/abstract-text/24569517/pubmed" id="24569517" target="_blank">24569517</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19902987">
<a name="19902987"></a>Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. <i>Clin Pharmacokinet</i>. 2009;48(12):761-804. doi:10.2165/11318070.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/guaifenesin-dextromethorphan-and-phenylephrine-drug-information/abstract-text/19902987/pubmed" id="19902987" target="_blank">19902987</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 8807 Version 317.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
